Monthly Archives: September 2017

Extend Biosciences is awarded a Phase II SBIR grant from NIDDK

Extend Biosciences’ long-acting PTH molecule will advance through IND-enabling studies with a Phase II grant from NIDDK.

NIDDK awards Extend Biosciences with a Phase I grant

Extend Biosciences was awarded a Phase I SBIR grant to advance their long-acting insulin molecule for the treatment of diabetes.